jay123 wrote:And after reading the email from the MS dept at Stanford gloating over beating Dr. Dake, do you really think designing and approving a new study is going to happen?
Sorry, I think so too, I should have said "approving a study in a timely manner is going to happen?" -
Some excerpts from the unconfirmed email like
"Please know that no patient seen or cared for at the Stanford MS Center has ever been referred for this procedure. We have without exception advised those who have made inquiry to NOT have this procedure performed. There are no metrics any of us would considerable reliable that suggest therapeutic benefit
; and there have been at least two serious adverse events as a consequence of CCVSI stenting. Effective immediately, this procedure has been SUSPENDED"
and the best
"We are in active communication with many interested organizations to let patients be aware that, contrary to the favorable reports they have been hearing , this is a procedure that cannot be defended, supported or recommended
on risk-benefit considerations at this time"
makes me wonder what type of cooperation he will get in forming a trial. I'll bet they will want simply a diagnostic trial to back up the Buffalo trial.